2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34564697 | Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells. | 2021 Sep 25 | 1 |
| 2 | 34659899 | Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations. | 2021 | 2 |